Overview
Top Medical Research Studies
Our findings revealed that when the mice were exposed to a compound known to induce inflammation, there was a noticeable rise in reactive oxygen species (ROS), signaling an increase in oxidative stress. This stress resulted in an uptick in certain harmful factors related to inflammation and cell death. However, when we introduced zinc as a supplement, it effectively reduced these damaging factors, alleviating inflammation and the resulting cell death in both the mouse stomach and cultured cells.
Overall, our study indicates that zinc supplementation can play a significant role in controlling inflammation and protecting against cellular damage caused by oxidative stress in chronic gastritis. By modulating the ROS/NF-κB signaling pathway, zinc demonstrates potential as a protective agent for gastric health.
Using a method called agar gel dilution, we found that 95% of the H. pylori strains tested were susceptible to ZnCl at a concentration of 40 μg/ml. This is a promising figure, especially when compared to 98% susceptibility for BSS and 79% for CLR. Interestingly, H. pylori isolates from patients with nonulcer dyspepsia and peptic ulcers showed similar levels of susceptibility to ZnCl.
It's important to note that while ZnCl demonstrated a significant antimicrobial effect against H. pylori, making it a potential candidate for treatment, the study also indicated that its effectiveness was comparable to CLR, but slightly less than BSS. This suggests that while ZnCl may be beneficial in treating H. pylori infections, it should not be viewed as a standalone solution, particularly in gastritis management.
Ultimately, our findings indicate that zinc chloride holds promise in tackling H. pylori, potentially contributing to improved treatment strategies for those suffering from gastritis and related disorders.
The study was structured with one group receiving the traditional 14-day standard treatment, which included esomeprazole, amoxicillin, and clarithromycin. The other group was treated with a 10-day regimen that added bismuth subcitrate and zinc carnosine to the same foundational therapies. After completing their courses, we retested the patients to assess the success of the eradication therapy.
Our findings revealed that the modified therapy group achieved a significantly higher eradication rate of 93.5% compared to just 69.6% in the standard treatment group. Besides dizziness, the side effects were similar between the two therapies, indicating that the addition of zinc carnosine did not introduce significant new risks.
This research suggests that zinc carnosine can be beneficial in enhancing the effectiveness of treatments for gastritis while maintaining a favorable safety profile. Therefore, those dealing with difficult-to-treat gastritis might find hope in this innovative approach.
Most Useful Reviews
Medical Researches
- All Researches
The study was structured with one group receiving the traditional 14-day standard treatment, which included esomeprazole, amoxicillin, and clarithromycin. The other group was treated with a 10-day regimen that added bismuth subcitrate and zinc carnosine to the same foundational therapies. After completing their courses, we retested the patients to assess the success of the eradication therapy.
Our findings revealed that the modified therapy group achieved a significantly higher eradication rate of 93.5% compared to just 69.6% in the standard treatment group. Besides dizziness, the side effects were similar between the two therapies, indicating that the addition of zinc carnosine did not introduce significant new risks.
This research suggests that zinc carnosine can be beneficial in enhancing the effectiveness of treatments for gastritis while maintaining a favorable safety profile. Therefore, those dealing with difficult-to-treat gastritis might find hope in this innovative approach.
To address his condition, the treatment regime included high protein supplements, proton pump inhibitors, and zinc-vitamin supplements. Over the course of five months, we observed a complete improvement in his symptoms. While this particular case emphasizes the role of zinc within a comprehensive treatment plan, it’s important to note that zinc was part of a multi-component strategy that makes it difficult to isolate its individual effects on gastritis directly.
Nonetheless, this case illustrates how early diagnosis and a well-structured treatment approach—integrating nutritional support—can lead to significant recovery in rare syndromes like CCS.
Our findings revealed that when the mice were exposed to a compound known to induce inflammation, there was a noticeable rise in reactive oxygen species (ROS), signaling an increase in oxidative stress. This stress resulted in an uptick in certain harmful factors related to inflammation and cell death. However, when we introduced zinc as a supplement, it effectively reduced these damaging factors, alleviating inflammation and the resulting cell death in both the mouse stomach and cultured cells.
Overall, our study indicates that zinc supplementation can play a significant role in controlling inflammation and protecting against cellular damage caused by oxidative stress in chronic gastritis. By modulating the ROS/NF-κB signaling pathway, zinc demonstrates potential as a protective agent for gastric health.
Our findings suggest that adding Polaprezinc to the triple therapy improved the eradication rates of the bacteria responsible for gastritis. Specifically, we observed a significant increase in successful treatment outcomes, indicating a potential advantage of Polaprezinc as a complementary approach.
However, it's important to note that while the combination therapy showed better results, both treatment groups reported similar instances of adverse events. This means that Polaprezinc appears to offer a beneficial effect on treatment outcomes without increasing side effects.
Despite these positive results, we recognize that the evidence is still limited. More extensive trials are needed to confirm these findings and establish Polaprezinc's role in gastritis management firmly. Overall, this treatment could be a promising addition but needs further exploration before becoming a standard approach.
Notably, we found that children with H. pylori had lower levels of serum ferritin and zinc compared to those without the infection. However, the copper levels remained unaffected. Interestingly, after treating the infected children, we observed significant improvements in their hemoglobin, ferritin, and zinc levels. This suggests that while zinc deficiency is often present in these patients, simply providing zinc treatment alone cannot solely isolate its specific impact on gastritis.
Furthermore, we noted that more severe gastritis correlated with lower hemoglobin and zinc levels, and higher transferrin receptor levels. Although zinc appears to play a crucial role in the overall health of these children, our findings indicate that its treatment effect should be viewed alongside other potential factors influencing gastritis recovery.
User Reviews
- All Reviews
- Positive Reviews
- Negative Reviews
Frequently Asked Questions
Gastritis is an inflammation of the stomach lining, which can lead to a range of symptoms including abdominal pain, nausea, vomiting, and indigestion. This condition can be acute, arising suddenly and lasting for a short period, or chronic, developing gradually and persisting over time. Various factors can contribute to gastritis, such as excessive alcohol consumption, prolonged use of nonsteroidal anti-inflammatory drugs (NSAIDs), bacterial infections (most notably Helicobacter pylori), and autoimmune disorders.
Treatment for gastritis often focuses on addressing the underlying cause and might include medications to reduce stomach acid, antibiotics for infections, and lifestyle modifications like avoiding irritating foods and beverages. While many people recover from gastritis with adequate care, it's important to consult a healthcare professional for a proper diagnosis and treatment plan. If left untreated, gastritis can lead to more serious complications, such as stomach ulcers or even an increased risk for gastric cancer.
Zinc is a versatile metal known for its various applications in industry and health. It is a bluish-white metallic element represented by the symbol Zn and atomic number 30 on the periodic table. Zinc is primarily used for galvanizing steel to prevent rusting, in the manufacturing of alloys, and as a component in batteries. Additionally, zinc plays a crucial role in biological processes, making it an essential trace element in the human diet. It is involved in immune function, protein synthesis, wound healing, and DNA synthesis, highlighting its importance in maintaining overall health and well-being.
Zinc is often recognized for its various health benefits, including its role in supporting the immune system and promoting wound healing. In the context of gastritis, which is an inflammation of the stomach lining, zinc may have a supportive role due to its potential anti-inflammatory properties and its involvement in cell regeneration. Some studies indicate that zinc supplements can help in healing gastric mucosal injuries and may alleviate symptoms associated with gastritis. However, the evidence is not definitive and varies based on the individual’s health status and the cause of their gastritis.
That said, it's essential to approach supplementation cautiously. While zinc can be beneficial, taking too much can lead to adverse effects, including nausea, diarrhea, and interference with the absorption of other essential minerals. If you suspect you have gastritis or are considering zinc supplements as part of your treatment plan, it’s always best to consult with a healthcare provider first. They can provide personalized advice and ensure that any supplements or changes in diet won't adversely affect your condition or interact with other medications you might be taking.
Based on user reviews, individuals taking this supplement for gastritis report varying timelines in experiencing relief and results. Some users, like one who suffers from atrophic gastritis, noted immediate comfort after switching to zinc bisglycinate, indicating a quick positive response to the supplement ((Read Review)). Others expressed satisfaction with the product's tolerance, stating that it has not irritated their stomach, which is crucial for those managing gastritis ((Read Review); (Read Review)).
However, not all users experienced immediate results. One user mentioned still feeling a heaviness in their stomach, albeit without nausea, suggesting that while the product is gentler than others, it might take time for some individuals to fully acclimate and experience significant benefits ((Read Review)). Consequently, results may manifest anywhere from a few days to several weeks, depending on individual responses and sensitivities.
Numerous studies suggest that zinc supplementation may offer significant benefits for individuals suffering from gastritis, particularly those affected by Helicobacter pylori infections. A systematic review examining polaprezinc, a zinc-l-carnosine complex, found that it improved eradication rates of H. pylori when used alongside standard triple therapy involving antibiotics. This suggests that polaprezinc could potentially enhance treatment outcomes for those dealing with gastritis related to this common bacterial infection [2]. Other studies have reinforced zinc's role in mitigating inflammation and cellular damage in gastric tissues, providing a compelling case for its protective effects in chronic gastritis [1].
Moreover, additional investigations have explored the efficacy of zinc chloride as a treatment option for H. pylori-associated gastritis, revealing promising antimicrobial activity [7]. However, while these findings endorse the use of zinc and its compounds in managing gastritis symptoms effectively, there is a consensus that further research is required to establish definitive treatment protocols. Thus, while the preliminary data support the potential of zinc supplementation in the context of gastritis, it's crucial for patients to consult healthcare professionals before beginning any supplement regimen [6].
Users report a range of improvements in symptoms related to gastritis when taking zinc bisglycinate. Many individuals, including those with sensitive stomachs or conditions like atrophic gastritis, found that this chelated form of zinc significantly reduced discomfort associated with regular zinc supplements. One user noted that after making the switch, they were able to take it comfortably without experiencing typical side effects, such as stomachaches or the appearance of white spots on their nails ((Read Review)). Another user echoed this sentiment, expressing satisfaction that the supplement did not irritate their stomach, making it an excellent choice for those managing gastritis ((Read Review); (Read Review)).
However, experiences can vary. Some users mentioned still feeling a heaviness in their stomach after taking the supplement, even if they didn't experience nausea, indicating that while many found relief, others might take a little longer to fully adapt and see a notable difference in their symptoms ((Read Review)). Overall, it appears that zinc bisglycinate can offer a gentler alternative for those with gastritis, providing varying degrees of relief and tolerance.
Users report that combining zinc bisglycinate with other supplements or medications can yield favorable results for managing gastritis symptoms. One user with autoimmune atrophic gastritis highlighted the advantages of choosing the chelated form of zinc, noting that it is absorbed more effectively and can be taken alongside other medications without gastrointestinal discomfort ((Read Review)). This aligns with experiences from other users who found that zinc bisglycinate was gentler on their stomachs compared to traditional zinc supplements, making it easier to integrate into their existing regimens ((Read Review); (Read Review)).
However, it's also worth noting that while many users experienced relief, some still reported a lingering heaviness in the stomach when taking the supplement, stressing the importance of adequate hydration, such as drinking more water alongside it ((Read Review)). Overall, the feedback suggests that zinc bisglycinate may offer a tolerable option for those managing gastritis, particularly in combination with other treatments, but individual responses can vary.
Based on user reviews, there appears to be a consensus leaning towards zinc bisglycinate as the preferred form of zinc for those suffering from gastritis. Users reported that this chelated form is easier on the stomach and does not cause the same irritation that other zinc supplements might. One user specifically noted, "If you have stomach discomfort with zinc, try zinc bisglycinate" (Read Review). Another echoed a similar sentiment, stating, "I found this Zinc very effective, as it does not irritate my stomach" (Read Review).
In terms of dosage, users typically reported taking one zinc supplement at a time and combining it with other medications, especially in cases of chronic gastritis. For instance, a reviewer mentioned opting for a chelated form due to its better absorption in individuals with autoimmune conditions (Read Review). Overall, users have found success with doses that allow for daily intake without causing stomach discomfort, particularly when accompanied by additional water (Read Review). While individual experiences may vary, zinc bisglycinate seems to stand out as a recommended option for managing gastritis symptoms.
Our findings suggest that adding Polaprezinc to the triple therapy improved the eradication rates of the bacteria responsible for gastritis. Specifically, we observed a significant increase in successful treatment outcomes, indicating a potential advantage of Polaprezinc as a complementary approach.
However, it's important to note that while the combination therapy showed better results, both treatment groups reported similar instances of adverse events. This means that Polaprezinc appears to offer a beneficial effect on treatment outcomes without increasing side effects.
Despite these positive results, we recognize that the evidence is still limited. More extensive trials are needed to confirm these findings and establish Polaprezinc's role in gastritis management firmly. Overall, this treatment could be a promising addition but needs further exploration before becoming a standard approach.
Our findings revealed that when the mice were exposed to a compound known to induce inflammation, there was a noticeable rise in reactive oxygen species (ROS), signaling an increase in oxidative stress. This stress resulted in an uptick in certain harmful factors related to inflammation and cell death. However, when we introduced zinc as a supplement, it effectively reduced these damaging factors, alleviating inflammation and the resulting cell death in both the mouse stomach and cultured cells.
Overall, our study indicates that zinc supplementation can play a significant role in controlling inflammation and protecting against cellular damage caused by oxidative stress in chronic gastritis. By modulating the ROS/NF-κB signaling pathway, zinc demonstrates potential as a protective agent for gastric health.
Using a method called agar gel dilution, we found that 95% of the H. pylori strains tested were susceptible to ZnCl at a concentration of 40 μg/ml. This is a promising figure, especially when compared to 98% susceptibility for BSS and 79% for CLR. Interestingly, H. pylori isolates from patients with nonulcer dyspepsia and peptic ulcers showed similar levels of susceptibility to ZnCl.
It's important to note that while ZnCl demonstrated a significant antimicrobial effect against H. pylori, making it a potential candidate for treatment, the study also indicated that its effectiveness was comparable to CLR, but slightly less than BSS. This suggests that while ZnCl may be beneficial in treating H. pylori infections, it should not be viewed as a standalone solution, particularly in gastritis management.
Ultimately, our findings indicate that zinc chloride holds promise in tackling H. pylori, potentially contributing to improved treatment strategies for those suffering from gastritis and related disorders.
Our findings revealed that patients receiving polaprezinc along with triple therapy had a significantly higher success rate in eradicating H. pylori compared to those who only received the triple therapy. Specifically, those in the group with standard dose polaprezinc achieved an eradication rate of about 77%, dramatically better than the 58.6% seen in the control group.
Additionally, all groups reported improvements in symptoms after treatment. However, it's important to note that the higher dosage of polaprezinc was linked to a slightly increased rate of adverse events. Despite this, there were no serious side effects noted across any group.
Overall, we observed that incorporating standard dose polaprezinc improves H. pylori eradication rates without significantly raising toxicity, suggesting that zinc can be a valuable addition to the treatment regimen for gastritis affected by this bacteria.
References
- Sun X, Xu S, Liu T, Wu J, Yang J, et al. Zinc supplementation alleviates oxidative stress to inhibit chronic gastritis the ROS/NF-κB pathway in a mouse model. Food Funct. 2024;15:7136. doi:10.1039/d4fo01142b
- Mahmoud A, Abuelazm M, Ahmed AAS, Abdalshafy H, Abdelazeem B, et al. Efficacy and Safety of Polaprezinc-Based Therapy versus the Standard Triple Therapy for Eradication: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2022;14. doi:10.3390/nu14194126
- Elsaadany E, Amin S, Abdel-Hafez M, El Amrousy D, Kasem S, et al. Study of Serum Ferritin, Zinc, and Copper Levels in Children With Helicobacter pylori Gastritis and the Effect of the Treatment. J Pediatr Gastroenterol Nutr. 2022;75:e88. doi:10.1097/MPG.0000000000003585
- Lenti MV, Facciotti F, Miceli E, Vanoli A, Fornasa G, et al. Mucosal Overexpression of Thymic Stromal Lymphopoietin and Proinflammatory Cytokines in Patients With Autoimmune Atrophic Gastritis. Clin Transl Gastroenterol. 2022;13:e00510. doi:10.14309/ctg.0000000000000510
- Ibrahim N, El Said H, Choukair A. Zinc carnosine-based modified bismuth quadruple therapy standard triple therapy for eradication: A randomized controlled study. World J Clin Cases. 2022;10:227. doi:10.12998/wjcc.v10.i1.227
- Tan B, Luo HQ, Xu H, Lv NH, Shi RH, et al. Polaprezinc combined with clarithromycin-based triple therapy for Helicobacter pylori-associated gastritis: A prospective, multicenter, randomized clinical trial. PLoS One. 2017;12:e0175625. doi:10.1371/journal.pone.0175625
- Yakoob J, Abbas Z, Usman MW, Awan S, Naz S, et al. Comparison of antimicrobial activity of zinc chloride and bismuth subsalicylate against clinical isolates of Helicobacter pylori. Microb Drug Resist. 2014;20:305. doi:10.1089/mdr.2013.0086
- Lipin SP, Paul B, Nazimudeen E, Jacob BS. Case of Cronkhite Canada syndrome shows improvement with enteral supplements. J Assoc Physicians India. 2012;60:61.
